1. Home
  2. PHAR vs LYTS Comparison

PHAR vs LYTS Comparison

Compare PHAR & LYTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAR
  • LYTS
  • Stock Information
  • Founded
  • PHAR 1988
  • LYTS 1976
  • Country
  • PHAR Netherlands
  • LYTS United States
  • Employees
  • PHAR N/A
  • LYTS N/A
  • Industry
  • PHAR Biotechnology: Pharmaceutical Preparations
  • LYTS Building Products
  • Sector
  • PHAR Health Care
  • LYTS Consumer Discretionary
  • Exchange
  • PHAR Nasdaq
  • LYTS Nasdaq
  • Market Cap
  • PHAR 618.3M
  • LYTS 551.1M
  • IPO Year
  • PHAR N/A
  • LYTS N/A
  • Fundamental
  • Price
  • PHAR $8.42
  • LYTS $21.20
  • Analyst Decision
  • PHAR Strong Buy
  • LYTS Strong Buy
  • Analyst Count
  • PHAR 3
  • LYTS 2
  • Target Price
  • PHAR $27.00
  • LYTS $28.00
  • AVG Volume (30 Days)
  • PHAR 5.6K
  • LYTS 188.7K
  • Earning Date
  • PHAR 03-13-2025
  • LYTS 01-23-2025
  • Dividend Yield
  • PHAR N/A
  • LYTS 0.95%
  • EPS Growth
  • PHAR N/A
  • LYTS N/A
  • EPS
  • PHAR N/A
  • LYTS 0.76
  • Revenue
  • PHAR $285,745,000.00
  • LYTS $523,020,999.00
  • Revenue This Year
  • PHAR $20.08
  • LYTS $17.21
  • Revenue Next Year
  • PHAR $9.22
  • LYTS $9.55
  • P/E Ratio
  • PHAR N/A
  • LYTS $27.56
  • Revenue Growth
  • PHAR 30.64
  • LYTS 10.45
  • 52 Week Low
  • PHAR $6.65
  • LYTS $13.40
  • 52 Week High
  • PHAR $13.20
  • LYTS $25.50
  • Technical
  • Relative Strength Index (RSI)
  • PHAR 40.05
  • LYTS 54.12
  • Support Level
  • PHAR $7.95
  • LYTS $20.27
  • Resistance Level
  • PHAR $9.35
  • LYTS $21.97
  • Average True Range (ATR)
  • PHAR 0.52
  • LYTS 1.05
  • MACD
  • PHAR -0.16
  • LYTS 0.03
  • Stochastic Oscillator
  • PHAR 22.76
  • LYTS 29.66

About PHAR Pharming Group N.V.

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

About LYTS LSI Industries Inc.

LSI Industries Inc provides corporate visual image solutions to the petroleum and convenience store industry. The company's operating segments include Lighting and Display Solutions. It generates maximum revenue from the Lighting segment. Lighting Segment manufactures and markets outdoor and indoor lighting and lighting controls for the commercial, industrial, and multi-site retail markets including the petroleum/convenience store, quick-service, and automotive markets. The Display Solutions Segment manufactures, sells and installs exterior and interior visual image and display elements, including printed graphics, structural graphics, digital signage, menu board systems, display fixtures, refrigerated displays, and custom display elements.

Share on Social Networks: